Ten-year treatment outcomes of consolidation hyperthermic intraperitoneal chemotherapy for ovarian cancer (HIPEC-KOV-03R).

Ji Geun Yoo Myong Cheol Lim Eun Young Park Imhyeon Kim Myong Cheol Lim Sung-Jong Lee

Published in: Journal of gynecologic oncology (2023)

The consolidation HIPEC demonstrated a significant improvement in 10-year PFS but not OS, with acceptable toxicity in patients with primary epithelial ovarian cancer. Further randomized controlled trials are warranted to confirm these results.

Keyphrases

randomized controlled trial
oxidative stress
locally advanced
systematic review
meta analyses
clinical trial
oxide nanoparticles